Related Experiment Videos
Pericardiectomy and coronary artery bypass grafting for constrictive pericarditis after heart surgery
1Division of Cardiovascular Surgery, Hyogo Brain and Heart Center, Himeji, Japan.
Insights
A 63-year-old male with chronic heart failure underwent successful pericardiectomy and coronary bypass surgery. This intervention improved his cardiac function, allowing him to transition from severe symptoms to mild symptoms with reduced medication.
Area of Science:
- Cardiology
- Cardiac Surgery
- Heart Failure Management
Background:
- A 63-year-old male presented with chronic heart failure (NYHA class III) secondary to myocardial ischemia and constrictive pericarditis post-cardiac surgery.
- The patient required high-dose diuretic therapy for symptom management.
Observation:
- The patient underwent a combined pericardiectomy and coronary artery bypass grafting (CABG) procedure.
- The surgery was performed without the use of cardiopulmonary bypass.
Findings:
- Post-operative assessment revealed improved cardiac function.
- The coronary bypass graft remained patent, indicating successful revascularization.
- One year after surgery, the patient's heart failure symptoms significantly improved to NYHA class I.
Implications:
- This case highlights the potential benefit of combined pericardiectomy and off-pump CABG in select patients with ischemic heart failure and constrictive pericarditis.
- Successful surgical intervention can lead to substantial recovery of cardiac function and improved quality of life.
- Reduced diuretic dependence post-surgery indicates significant hemodynamic improvement.
Abstract:
A 63-year-old male was operated on for chronic heart failure due to myocardial ischemia and constrictive pericarditis after heart surgery. He was in New York Heart Association (NYHA) class III under a large dose of diuretics. He underwent a pericardiectomy and coronary bypass surgery without cardiopulmonary bypass. His cardiac function improved with a patent graft. He is now, 1 year after surgery, in NYHA class I under a tapering dose of diuretics.